Free shipping on all orders over $ 500

Insulin Receptor Insulin Receptor

Cat.No.  Name Information
M54753 AVJ16 AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 to inhibit the migration of H1299 cells with high endogenous IGF2BP1 expression.
M50422 S961 S961 is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.
M22472 Insulin degludec Insulin degludec is an ultra-long-acting form of insulin, shows binding efficiency with an IC50 value of 19.59 nM/L for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.
M11317 S961 TFA S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 of 0.048 for HIR-A, HIR-B and higF-IR, respectively. 0.027 and 630 nM.
M6662 Demethylasterriquinone B1 Demethylasterriquinone B1 is a selective insulin RTK activator.
M4598 Rhoifolin RhoifolinRhoifolin is a flavonoid glycoside isolated from the leaves of Guanxi pomelo (Citrus Grandis). Rhoifolin is beneficial to diabetic complications by enhancing adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and translocation of GLUT4. Rhoifolin ameliorates titanium-stimulated osteolysis and attenuates osteoclast formation through ranKL-induced NF-κB and MAPK pathways.
M4100 Kaempferitrin Kaempferitrin is a natural flavonoid glycoside with pain relief, anti-inflammatory, anti-diabetes, anti-tumor and other effects, and can activate insulin signaling.
M3734 KU14R KU14R is a new I(3)-R antagonist that selectively blocks the insulin secretory response to imidazolines.
M54458 [D-Ala2]-GIP (human) [D-Ala2]-GIP (human) is a GIP receptor agonist.
M54271 Gastric Inhibitory Peptide, porcine Gastric Inhibitory Peptide, porcine is a glucose-dependent insulinotropic polypeptide, is a 42 amino acid intestinal hormone with effects on fat and glucose metabolism.
M53985 (Pro3) GIP, human (Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist.
M53852 GIP (3-42), human GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.
M50424 [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
M50423 GIP (1-30) amide, porcine GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42).
M50421 CMX-2043 CMX-2043 is a novel analogue of α-Lipoic Acid.
M50420 DA-JC4 DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.
M50419 Acetyl Gastric Inhibitory Peptide (human) Acetyl Gastric Inhibitory Peptide (human) is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
M50418 Gastric Inhibitory Polypeptide (1-30), porcine Gastric Inhibitory Polypeptide (1-30), porcine lacks the C-terminal 12 amino acid residues of natural gastric inhibitory polypeptide (GIP), exhibits biologic activity by potentiating the release of insulin and somatostatin.
M50417 [Tyr0] Gastric Inhibitory Peptide (23-42), human [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion.
M50416 GIP (1-30) amide, human GIP (1-30) amide,human is a glucose-dependent insulinotropic polypeptide (GIP) fragment.

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.